Compare · EYE vs RXST
EYE vs RXST
Side-by-side comparison of National Vision Holdings Inc. (EYE) and RxSight Inc. (RXST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EYE and RXST operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- EYE is the larger of the two at $1.48B, about 5.6x RXST ($266.2M).
- EYE has been more active in the news (8 items in the past 4 weeks vs 5 for RXST).
- RXST has more recent analyst coverage (25 ratings vs 20 for EYE).
- Company
- National Vision Holdings Inc.
- RxSight Inc.
- Price
- -
- -
- Market cap
- $1.48B
- $266.2M
- 1M return
- -
- +13.35%
- 1Y return
- -
- -24.54%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2021
- News (4w)
- 8
- 5
- Recent ratings
- 20
- 25
National Vision Holdings Inc.
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 2, 2021, the company operated through 1,205 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
RxSight Inc.
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Latest EYE
- Chief Executive Officer Wilkes Alexander converted options into 61,786 shares and covered exercise/tax liability with 29,884 shares, increasing direct ownership by 136% to 55,441 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by National Vision Holdings Inc.
- SEC Form 10-Q filed by National Vision Holdings Inc.
- National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
- Amendment: SEC Form SCHEDULE 13G/A filed by National Vision Holdings Inc.
- SEC Form SCHEDULE 13G filed by National Vision Holdings Inc.
- Chief Executive Officer Wilkes Alexander converted options into 13,768 shares and covered exercise/tax liability with 6,660 shares, increasing direct ownership by 43% to 23,539 units (SEC Form 4)
- National Vision Holdings, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call
- President, America's Best Banner Mark converted options into 11,728 shares and covered exercise/tax liability with 4,964 shares, increasing direct ownership by 38% to 24,603 units (SEC Form 4)
Latest RXST
- Amendment: SEC Form SC TO-I/A filed by RxSight Inc.
- SEC Form SC TO-I filed by RxSight Inc.
- SEC Form 10-Q filed by RxSight Inc.
- RxSight Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
- RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
- SEC Form 4 filed by President and CEO Mottiwala Aziz
- SEC Form 3 filed by new insider Mottiwala Aziz
- SEC Form S-8 filed by RxSight Inc.
- RxSight Inc. filed SEC Form 8-K: Regulation FD Disclosure